Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+၁.၄၀%
၁,၀၅၆.၀၈
+၁၄.၅၅
+၁.၄၀%
၁,၀၄၁.၅၃၁,၀၃၉.၄၆၁,၀၅၇.၀၅၁,၀၃၈.၅၁
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၇%
၆၀၆.၉၀
+၁.၆၄
+၀.၂၇%
၆၀၅.၂၆၆၀၅.၂၆၆၀၇.၄၁၆၀၀.၁၇
SIXE
Energy
SIXE
Energy
SIXE
-၂.၄၂%
၁,၂၅၁.၇၁
-၃၁.၀၃
-၂.၄၂%
၁,၂၈၂.၇၄၁,၂၈၁.၅၉၁,၂၉၁.၃၆၁,၂၄၉.၅၈
SIXI
Industrials
SIXI
Industrials
SIXI
+၁.၂၀%
၁,၇၂၀.၆၄
+၂၀.၃၇
+၁.၂၀%
၁,၇၀၀.၂၇၁,၇၀၁.၅၇၁,၇၂၈.၂၈၁,၆၉၇.၅၅
SIXM
Financials
SIXM
Financials
SIXM
+၁.၀၆%
၆၃၆.၀၁
+၆.၇၀
+၁.၀၆%
၆၂၉.၃၁၆၂၉.၄၉၆၃၆.၇၅၆၂၅.၅၃
SIXR
Staples
SIXR
Staples
SIXR
-၀.၆၉%
၈၆၁.၈၈
-၅.၉၅
-၀.၆၉%
၈၆၇.၈၃၈၆၆.၅၃၈၆၇.၈၇၈၅၅.၂၁
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+၁.၁၆%
၂၁၈.၀၈
+၂.၅၁
+၁.၁၆%
၂၁၅.၅၇၂၁၅.၅၇၂၁၈.၀၈၂၁၅.၄၀
SIXT
Technology
SIXT
Technology
SIXT
+၂.၂၇%
၃,၅၆၆.၉၇
+၇၉.၁၀
+၂.၂၇%
၃,၄၈၇.၈၇၃,၅၁၄.၇၁၃,၅၆၇.၈၉၃,၅၀၂.၉၇
SIXU
Utilities
SIXU
Utilities
SIXU
+၀.၄၀%
၈၉၉.၂၇
+၃.၅၅
+၀.၄၀%
၈၉၅.၇၂၈၉၉.၃၃၉၀၅.၇၉၈၉၆.၉၇
SIXV
Health care
SIXV
Health care
SIXV
-၀.၀၇%
၁,၄၈၅.၄၇
-၁.၀၀
-၀.၀၇%
၁,၄၈၆.၄၇၁,၄၈၇.၃၆၁,၄၉၃.၆၀၁,၄၇၆.၆၄
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၂.၅၆%
၂,၃၈၃.၀၆
+၅၉.၄၉
+၂.၅၆%
၂,၃၂၃.၅၇၂,၃၂၇.၈၈၂,၃၈၃.၂၀၂,၃၁၉.၅၉
ARCT:NASDAQ
Arcturus Therapeutics Holdings Inc
၆.၈၂ US$
+၁.၉၄%
(+၀.၁၃) 1D
၆.၈၄ US$
+၀.၂၈% (+၀.၀၁၉)
Pre-market
Closed: မေ ၂၀, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARCT...
Open
၆.၇၀ US$
High
၆.၉၅ US$
Low
၆.၇၀ US$
Mkt. cap
၁၉.၃၈ ကုဋေ
Avg. vol.
၄.၁၉ သိန်း
Volume
၂၅၀.၀၀
52-wk high
၂၄.၁၄ US$
52-wk low
၅.၈၆ US$
EPS
-၂.၈၂ US$
Beta
၂.၄၃
Shares outstanding
၂.၈၄ ကုဋေ
No. of employees
၁၀၉
News stories
From sources across the web
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၂၇ မိနစ်
AI handles 3 of 4 patient calls as CareCloud cuts $140M prefs
Nasdaq
Nasdaq
·
ပြီးခဲ့သည့် ၄၃ မိနစ်
AIR Global PLC Rings the Opening Bell
The Motley Fool
The Motley Fool
·
ပြီးခဲ့သည့် ၄၃ မိနစ်
The Most Undervalued Healthcare Stock in the S&P 500 Right Now
Barron's
Barron's
·
ပြီးခဲ့သည့် ၅၇ မိနစ်
S&P 500 Futures Fall in Premarket Trading; D-Wave Quantum, Rigetti Computing Lead
Profile
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA, messenger RNA, gene editing RNA, DNA, antisense oligonucleotides, and microRNA. The company develops RNA therapeutics for the treatment of rare diseases such as ornithine transcarbamylase deficiency, and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19 and an influenza vaccine in the preclinical development phase. The vaccine for COVID-19 was authorised in Japan in 2023 and the European Union in 2025. Wikipedia
About Arcturus Therapeutics Holdings Inc
CEOJoseph E. Payne
Employees၁၀၉
Founded၂၀၁၃
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၂.၈၃ ကုဋေ
၁.၇၂ ကုဋေ
၇.၂၀ သန်း
၂.၀၆ သန်း
Cost of goods sold
၂.၉၆ ကုဋေ
၂.၃၃ ကုဋေ
၂.၄၅ ကုဋေ
၂.၁၅ ကုဋေ
Cost of revenue
၂.၉၆ ကုဋေ
၂.၃၃ ကုဋေ
၂.၄၅ ကုဋေ
၂.၁၅ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၀၃ ကုဋေ
၁.၀၄ ကုဋေ
၁.၄၀ ကုဋေ
၉.၄၆ သန်း
Operating expense
၁.၀၃ ကုဋေ
၁.၀၄ ကုဋေ
၁.၄၀ ကုဋေ
၉.၄၆ သန်း
Total operating expenses
၃.၉၉ ကုဋေ
၃.၃၇ ကုဋေ
၃.၈၅ ကုဋေ
၃.၁၀ ကုဋေ
Operating income
-၁.၁၆ ကုဋေ
-၁.၆၅ ကုဋေ
-၃.၁၃ ကုဋေ
-၂.၈၉ ကုဋေ
Other non operating income
-
-
-
၃.၅၀ သောင်း
EBT including unusual items
-၉.၁၈ သန်း
-၁.၃၄ ကုဋေ
-၂.၉၁ ကုဋေ
-၂.၇၀ ကုဋေ
EBT excluding unusual items
-၉.၁၈ သန်း
-၁.၃၄ ကုဋေ
-၂.၉၁ ကုဋေ
-၂.၇၀ ကုဋေ
Income tax expense
၄.၀၀ ထောင်
-
-၄.၀၀ ထောင်
-
Effective tax rate
-၀.၀၄%
-
၀.၀၁%
-
Other operating expenses
-
-
-
-
Net income
-၉.၁၈ သန်း
-၁.၃၄ ကုဋေ
-၂.၉၁ ကုဋေ
-၂.၇၀ ကုဋေ
Net profit margin
-၃၂.၄၄%
-၇၈.၄၁%
-၄၀၄.၁၀%
-၁,၃၀၈.၃၀%
Earnings per share
-၀.၃၄
-၀.၄၉
-၁.၀၃
-၀.၉၅
Interest and investment income
၂.၅၇ သန်း
၃.၂၃ သန်း
၁.၅၃ သန်း
၁.၉၃ သန်း
Interest expense
-
-
-၉.၀၀ ထောင်
-
Net interest expenses
၂.၅၇ သန်း
၃.၂၃ သန်း
၁.၅၂ သန်း
၁.၉၃ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၈ ကုဋေ
-၁.၅၇ ကုဋေ
-၃.၀၆ ကုဋေ
-၂.၈၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-၃.၄၀ သောင်း
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more